Clinical trial
Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania
NCT00118014 · Massachusetts General Hospital, Other · Completed
Key facts
| NCT number | NCT00118014 |
|---|---|
| Title | Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania |
| Official title | Sertraline and Habit Reversal in the Treatment of Patients With Trichotillomania |
| Lead sponsor | Massachusetts General Hospital, Other |
| Collaborators | Pfizer Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Impulse Control Disorders |
| Intervention type | Behavioral, Drug |
| Interventions | Sertraline, Habit Reversal Training |
| Enrollment | 75 |
| Start date | Jan 1, 2000 |
| Primary completion | Apr 1, 2004 |
| Completion | Aug 1, 2004 |
| First posted | Jul 11, 2005 |
| Last update posted | May 20, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: